Onconetix (ONCO) Raw Materials (2023 - 2026)
Onconetix (ONCO) posted quarterly Raw Materials of $95570.0 for Q1 2026, up 4.82% year-over-year from $91174.0 in Q1 2025, and down 7.6% quarter-over-quarter from $103431.0 in Q4 2025.
Onconetix (ONCO) Raw Materials (2023 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Raw Materials for 4 consecutive years, with $95570.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Raw Materials rose 4.82% year-over-year to $95570.0; the TTM figure through Mar 2026 stood at $95570.0 (up 4.82% YoY), while the FY2025 annual figure was $103431.0, up 80.05% from the prior year.
- Raw Materials slipped to $95570.0 in Q1 2026 per ONCO's latest filing, from $103431.0 in the prior quarter.
- Across five years, Raw Materials topped out at $329780.0 in Q3 2023 and bottomed at $57446.0 in Q4 2024.
- Historically, Raw Materials has averaged $133234.9 across 4 years, with a median of $103423.0 in 2025.
- Annual changes were most pronounced in 2024 — Raw Materials tumbled 70.31% — and 2025, when it jumped 80.05%.
- Onconetix's Raw Materials stood at $139208.0 in 2023, then plunged by 58.73% to $57446.0 in 2024, then surged by 80.05% to $103431.0 in 2025, then declined by 7.6% to $95570.0 in 2026.
- Business Quant data shows ONCO's Raw Materials at $95570.0 in Q1 2026, $103431.0 in Q4 2025, and $103415.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94,525.00 |
| Mar 31, 2026 | 95,570.00 |
| Dec 31, 2025 | 103,431.00 |
| Sep 30, 2025 | 103,415.00 |
| Jun 30, 2025 | 103,711.00 |
| Mar 31, 2025 | 91,174.00 |
| Dec 31, 2024 | 57,446.00 |
| Sep 30, 2024 | 97,915.00 |
| Jun 30, 2024 | 91,971.00 |
| Mar 31, 2024 | 135,198.00 |
| Dec 31, 2023 | 139,208.00 |
| Sep 30, 2023 | 329,780.00 |
| Jun 30, 2023 | 250,000.00 |